Skip to main content

Table 2 Response of primary tumor and nodal status*

From: Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

Response N (%)
ypT:  
 0 3 (7.5)
 1 1 (2.5)
 2 12 (30.0)
 3 22 (55.0)
 4 1 (2.5)
 Not available* 1 (2.5)
ypN:  
 0 25 (62.5)
 1 13 (32.5)
 2 1 (2.5)
 Not available* 1 (2.5)
Tumor regression grade:  
 1 3 (7.0)
 2 8 (20.0)
 3 19 (47.5)
 4 9 (22.5)
 Not available* 1 (2.5)
  1. *One patient did not undergo surgery.